Cytokine interactions and cytokine balance in the brain: relevance to neurology and psychiatry Cytokine-cytokine and cytokine-neurotransmitter-neuropeptide interactions are pivotal for the magnitude of neurological and psychiatric manifestations, neuroimmunological and neuroinflammatory responses, and neurological complications of disorders associated with increased cytokine production.
Cytokine action on brain cells is an important component of a neuroimmunological and neuroinflammatory response. Cytokines are also involved in the induction of neurologic and psychiatric symptoms and signs that accompany acute and chronic disease. For example, fever and anorexia of disease involve cytokines. 1, 2 Immunotherapy with cytokines in humans is also associated with significant neurologic and psychiatric manifestations including fever, anorexia, fatigue and depression. 3, 4 We focus this brief paper on two critical issues in brain cytokine biology that relate directly to neurology and psychiatry: cytokine interactions and cytokine balance (see Image section).
Cytokine production is promoted during acute and chronic central nervous system (CNS) diseases (eg, meningitis, encephalitis, multiple sclerosis, Alzheimer's disease and brain tumors). 5, 6 Cytokine production also increases in the brain in response to peripheral disease; 7, 8 for example, prostate gland adenocarcinoma-bearing rats exhibit a significant upregulation of IL-1␤ mRNA (an indicator of local production) in the tumor, spleen, and discrete brain regions. 8 This evidence shows that the brain can respond to a peripheral pathophysiological process with the local production of cytokines.
Brain responses induced by individual cytokines have been well studied. However, generation of clinical manifestations involves both cytokine action per se and cytokine modulation of neurotransmitter and neuropeptide systems. 9 That is, interactions involving cytokines, neurotransmitters and neuropeptides are critical for the induction of neurologic and psychiatric symptoms and signs.
Cytokine-neurotransmitter interactions are reciprocal. For instance, cytokines can modify serotonin-and catecholamine-associated mechanisms in the brain. 9, 10 IL-1␤ stimulates the release of serotonin, norepinephrine, and dopamine from specific brain regions. On the other hand, serotonin and catecholamines also affect IL-1␤-mediated responses. 9 Cytokine-neuropeptide interactions also exhibit reciprocal modulation. IL-1␤, for example, modulates the secretion or action of corticotropin-releasing hormone, 12 which in turn, modulates IL-1␤ and/or production and release of other cytokines. 13 Cytokine-neuropeptide interactions can also be antagonistic. IL-1␤ blocks neuropeptide Yinduced feeding, and neuropeptide Y blocks IL-1␤-induced anorexia.
14 Neuropeptide Y also inhibits IFN-␣-induced adverse neurologic effects. 15 Neuropeptide/ hormones are also involved in these interactions, eg, IL-1␤ stimulates vasopressin release, 16 and vasopressin inhibits IL-1␤-induced fever. 16 Cytokines can also modify transductional systems coupled to neurotransmitter and neuropeptide receptors. For example, anorectic rats responding to IL-1␤ exhibit a specific decrease in the hypothalamic G-protein ␣-subunit G␣O, 17 a transducing molecule that is integral for the modulation of feeding. 18 IL-1␤-induced decrease of G␣O protein could inhibit the responsiveness of feeding-enhancing G-protein coupled receptors and this may be involved in IL-1␤-induced anorexia. Thus, for the purpose of integration, cytokine-induced modulation of G-proteins-the interface between convergence of multiple chemical signals and divergence to intracellular messengers-in brain sites may be involved in the generation of neurologic and psychiatric manifestations.
Next, we will focus our discussion on interactions among cytokines which play a pivotal role in neurologic and psychiatric manifestations, neuroimmunological responses, and possibly, neurodegenerative processes. Cytokine interactions also occur during immunoenhancement associated with cytokine immunotherapy. Within the brain, autocrine-paracrine cytokine interactions among cell-producing cytokines, ie, cerebrovascular endothelium, brain macrophages, Tcells, microglia, astrocytes and neurons, may occur. The net effect of cytokine interactions can be additive, synergistic, inhibitory, or antagonistic cellular responses.
Interactions among pro-inflammatory (eg, IL-1␤, IL-6, IL-8, TNF-␣) cytokines can result in synergistic activities in both cytokine production and cytokine action. Pro-inflammatory cytokine interactions are also associated with a synergistic induction of neurologic and psychiatric manifestations. 19 In fact, synergistic cytokine-induced anorexia occurs at estimated pathophysiological concentrations of cytokines in the cerebrospinal fluid. 20 The cytokine network involves various cytokine families (eg, interleukins, chemokines, TNF-␣, interferons). Members in each cytokine family use distinct receptors and signalling systems. However, their pathways can converge on downstream intracellular targets and amplify cellular processes. An example is the convergence of IL-1 and TNF-␣ signalling pathways to activate NF-kB-inducing kinase (NIK), a MAP3K-related kinase. 21, 22 This convergence results in the synergistic activation of transcriptional mechanisms. NF-kB is also activated by IL-6, and a synergistic response to IL-1, IL-6 plus TNF-␣ can involve a similar convergence of intracellular mechanisms via JAK-STAT (IL-6) and MAPK-NF-kB (IL-1␤, TNF-␣) pathways. 23 Another operational transductional process relates to homologous receptors that could use similar intracellular mediators; for example, leptin (a member of the long-chain cytokine family) acts through a receptor, the OB receptor, which is most related to glycoprotein 130, a common signal transducer among receptors for members of the IL-6 subfamily (eg, IL-6, ciliary neurotrophic factor and leukemia inhibitory factor). Leptin, as IL-6 members, exhibits pro-inflammatory activities and can stimulate components of the JAK-STAT pathway. Leptin acts as a satiety factor 24 and IL-6 members induce anorexia. 25 These lines of evidence suggest a possible mechanism that links pathways associated with CNS functions (eg, feeding control) in health (via leptin) and disease (via IL-6 members).
A second general category of cytokines is represented by inhibitory (anti-inflammatory) cytokines. These include IL-1 receptor antagonist (IL-1Ra), IL-4, IL-10, and transforming growth factor-␤1 (TGF-␤1). Inhibitory cytokines can suppress pro-inflammatory cytokine production and action. This action is critical to the concept of balance among pro-and anti-inflammatory cytokines. Cytokine balance considers two components, the first within a cytokine system (eg, IL-1 and IL-1Ra), and the second among different cytokine systems (eg, TGF-␤1 inhibiting IL-1 and TNF-␣ activities).
Cytokine interactions within a cytokine system have been best studied in the IL-1 system. IL-1 increases the synthesis and secretion of IL-1Ra. 26 Up-regulation of IL-1Ra is proposed to attenuate deleterious IL-1-induced effects by blocking IL-1 receptors and, thereby, providing cytoprotection, IL-1Ra, at the appropriate concentrations, inhibits IL-1␤-mediated mediated CNS biological and neurological activities in vitro and in vivo. 19 IL-1Ra production during pathological processes could be an important determinant of prognosis because neutralizing antibodies to endogenous IL-1Ra aggravate disease. 26 Thus, balance between IL-1Ra and IL-1␤ concentrations appears critical. Beneficial effects will be obtained with an appropriate IL-1Ra/IL-1␤ ratio. Excess of IL-1Ra is required to inhibit IL-1␤-induced responses because the IL-1 system exhibits spare receptor effects with maximal biological response observed with occupancy of Ͻ10% of IL-1 receptors. The clinical consequence of a CNS dysregulation in the IL-1Ra/IL-1␤ balance associated with a mutual induction and synergistic activity of IL-1␤ and TNF-␣ is a deleterious amplification cycle of cellular activation and cytotoxicity with implications to the magnitude of the neuroimmunological response and neurologic manifestations. 27 Cytokine interactions among cytokine systems have been studied with bacterial-derived products, eg, lipopolysaccharide (LPS) from Gram-negative and muramyl dipeptide (MDP) from Gram-positive bacteria. Bacterial products acting directly in the CNS induce a brain cytokine profile that correlates with the neurologic manifestations. 5, 28 LPS is significantly more potent than MDP in inducing anorexia and in up-regulating pro-inflammatory cytokines (IL-1␤ and TNF-␣) mRNAs in the cerebellum, hippocampus and hypothalamus ( Figure 1) . MDP, on the other hand, is more potent in up-regulating anti-inflammatory cytokines (IL-1Ra and TGF-␤1) mRNAs. This evidence suggests that the magnitude of neurologic manifestations induced by LPS and MDP involves the ratio between stimulatory and inhibitory cytokines.
In integrative terms, a balance between pro-inflammatory (eg, IL-1␤, IL-6, TNF-␣) and inhibitory (eg, IL1Ra, IL-4, IL-10, TGF-␤1) cytokines is pivotal for an appropriate modulation of cellular responses in the brain. An adequate balance will have beneficial effects. However, if severe clinical conditions are associated with high concentrations of pro-inflammatory cytokines and low activity of inhibitory mechanisms, the result could be an aggravation of the inflammatory and cytotoxic processes. This could be reflected in the magnitude of neurological manifestations, neuroinflammatory and neuroimmunological responses, neurotoxic events, pathogenicity and severity of neurological diseases involving immune activation, and neurological complications associated with high levels of cytokines in the brain. Clinical studies support this model. IL-1␤, IL-1Ra, TNF-␣ and TGF-␤1 increase in the cerebrospinal fluid of patients with infections of the CNS. [29] [30] [31] [32] High levels of IL-1 and TNF-␣ in the cerebrospinal fluid are associated with an increased rate of complications and poor prognosis. On the other hand, IL-1Ra and TGF-␤1 up-regulation could contribute to a lower rate of complications and positive outcomes in patients with bacterial meningitis.
In conclusion, cytokine involvement in neuroimmunological and neurodegenerative responses as well as in the induction of symptoms of disease involves interactions among cytokines, neurotransmitters, and neuropeptides. Cytokine-cytokine interactions with positive (IL-1, IL-6 and TNF-␣) and negative (IL-1Ra inhibition of IL-1␤; TGF-␤1 inhibition of IL-1␤/TNF-␣) feedback play critical roles in the brain neurochemical ). Samples from all three brain regions were analyzed concomitantly, the same rat provided all three brain regions, and the same samples were analyzed with all antisense probes. Modified from Reference 5. cascade associated with neuropathophysiological processes. However, although it is clear that endogenous interactive models of cytokine action and balance occur during CNS disease, various issues remain to be investigated. Relevant cytokine interactions are expected to vary depending on the disease process. Data are available with brain infections, but other neurological disorders require characterization of cytokine interactions and underlying dysregulation. Studies are in progress with brain tumors, 33 neurodegenerative disorders, and peripheral diseases associated with CNS symptoms and signs. 7, 8 We can conclude that characterization of cytokine-cytokine and cytokineneurotransmitter-neuropeptide interactions is important in the future of neurology and psychiatry. 
